Drug targeting with nano-sized carrier systems

Journal of Artificial Organs

Volumn 8, Issue 2, 2005, Pages 77-84

  Yokoyama, Masayuki ^a  

^a KANAGAWA ACADEMY OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Drug carrier; Drug targeting; EPR effect; Nano; Targeting

Indexed keywords

6 [4 DEOXY 4 (2,4 TETRADECADIENOYLGLYCYLAMINO) GLYCERO BETA MANNOHEPTOPYRANOSYLAMINO] 9H PURINE; ALEMTUZUMAB; ANTINEOPLASTIC AGENT; BEVACIZUMAB; BIOMATERIAL; CAMPTOTHECIN; CETUXIMAB; DOXORUBICIN; DRUG CARRIER; GANGLIOSIDE GM1; LIPOSOME; MACROGOL; MONOCLONAL ANTIBODY; NANOPARTICLE; PACLITAXEL; POLY[N (2 HYDROXYPROPYL)METHACRYLAMIDE]; POLYMER; PROSTAGLANDIN E1; RITUXIMAB; TRASTUZUMAB;

ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; ARTIFICIAL ORGAN; CANCER THERAPY; CHILL; CLINICAL TRIAL; CORRELATION ANALYSIS; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; FEVER; HAND FOOT SYNDROME; HUMAN; KAPOSI SARCOMA; LEUKOPENIA; METHODOLOGY; MICELLE; PRIORITY JOURNAL;

DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NANOSTRUCTURES; NANOTECHNOLOGY; PHARMACEUTICAL PREPARATIONS;

EID: 23744471772     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10047-005-0285-0     Document Type: Article

References (47)

1. M Yokoyama T Okano 1996 Targetable drug carriers: present status and a future perspective Adv Drug Deliv Rev 21 77 80
2. Y Sugiyama 1996 Importance of pharmacokinetic considerations in the development of drug delivery systems Adv Drug Deliv Rev 19 333 334
3. Y Takakura K Maruyama M Yokoyama 1999 Passive targeting of drugs (in Japanese) Drug Deliv Syst 14 425 426
4. Y Matsumura H Maeda 1986 A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res 46 6387 6392
5. H Maeda 2001 The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv Enzyme Regul 41 189 207
6. DC Litzinger AMJ Buiting N van Rooijen L Huang 1994 Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes Biochim Biophys Acta 1190 99 107
7. LW Seymour Y Miyamoto H Maeda M Brereton J Strohalm K Ulbrich R Duncan 1995 Influence of molecular weight on passive tumor accumulation of a soluble macromolecular drug Eur J Cancer 31A 766 770
8. PR Hamann MS Berger 2002 Mylotarg: the first antibody-targeted chemotherapy agent M Page Tumor targeting in cancer therapy Humana Press Totowa 239 254
9. PA Trail D Willner SJ Lasch AJ Henderson S Hofstead AM Casazza RA Firestone KE Hellstrom 1993 Cure of xenografted human carcinomas by BR-96-doxorubicin immunoconjugates Science 261 212 215
10. D Putnam J Kopecek 1995 Polymer conjugates with anticancer activity Adv Polymer Sci 122 55 123
11. R Duncan S Dimitrijevic EG Evagorou 1996 The role of polymer conjugates in the diagnosis and treatment of cancer STP Pharma Sci 6 237 263
12. B Rihova M Biley V Vetvicka K Ulbrich J Strohalm J Kopecek R Duncan 1989 Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin Biomaterials 10 335 342
13. SA Cartlidge R Duncan JB Lloyd PK Rejmanova J Kopecek 1987 Soluble, crosslinked N-(2-hydroxypropyl) methacrylamide copolymers as potential drug carriers. 2: Effect of molecular weight on blood clearance and body distribution in the rat after intravenous administration. Distribution of unfractionated copolymer after intraperitoneal, subcutaneous or oral administration J Contr Rel 4 253 264
14. LW Seymour R Duncan J Strohalm J Kopecek 1987 Effect of molecular weight of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats J Biomed Mater Res 21 1341 1358
15. R Duncan LW Seymour KB O'Hare PA Flanagan S Wedge IC Hume K Ulbrich J Strohalm V Subr F Spreafico M Grandi M Ripamonti M Farao A Suarato 1992 Preclinical evaluation of polymer-bound doxorubicin J Contr Rel 19 331 346
16. PA Flanagan R Duncan V Subr K Ulbrich P Kopecekova J Kopecek 1992 Evaluation of protein-N-(2-hydroxypropyl) methacrylamide copolymer conjugates as targetable drug carriers. 2. Body distribution of conjugates containing transferrin, anti-transferrin receptor antibody or anti-Thy 1.2 antibody and effectiveness of transferrin-containing daunomycin conjugates against mouse L 1210 leukaemia in vivo J Contr Rel 18 25 38
17. SR Wedge R Duncan P Kopeckova 1991 Comparison of the liver subcelluar distribution of free daunomycin and that bound to galactosamine targeted N-(2-hydroxypropyl)methacrylamide copolymers, following intravenous administration in the rat Br J Cancer 63 546 549
18. Y Mizushima Y Shiokawa S Kashiwazaki Y Ichikawa H Hashimoto A Sakuma 1987 A multicenter double-blind controlled study of lipo-PGE1, PGE1 incorporated in lipid microspheres, in peripheral vascular disease secondary to connective tissue disorders J Rheumatol 14 97 101
19. TM Allen A Chonn 1987 Large unilamellar liposomes with low uptake into the reticuloendothelial system FEBS Lett 223 42 46
20. MC Woodle DD Lasic 1992 Sterically stabilized liposomes Biochim Biophys Acta 1113 171 199
21. B Uriely S Jeffers R Isacson K Kutsch D Wei-Tsao Z Yehoshua E Libson FM Muggia S Gabizon 1995 Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies J Clin Oncol 13 1777 1785
22. H Bader H Ringsdorf 1984 Watersoluble polymers in medicine Angew Makromol Chem 123/124 457 485
23. M Yokoyama 1992 Block copolymers as drug carriers Crit Rev Ther Drug Carrier Syst 9 213 248
24. M Yokoyama 1994 Site-specific drug delivery using polymeric carriers Advances in polymeric systems for drug delivery Gordon and Breach Yverdon, Switzerland 24 66
25. M Yokoyama 1998 Novel passive targetable drug delivery with polymeric micelles T Okano Biorelated polymers and gels: controlled release and applications in biomedical engineering Academic San Diego 193 230
26. A Lavasanifar J Samuel GS Kwon 2002 Poly(ethylene oxide)-block-poly(l- amino acid) micelles for drug delivery Adv Drug Deliv Rev 54 169 190
27. Z Tuzar P Kratochvil 1976 Block and graft copolymer micelles in solution Adv Colloid Interfac Sci 6 201 232
28. AV Kabanov VP Chekhonin VY Alakhov EV Batrakova AS Lebedev NS Melik-Nubarov SA Arzhakov AV Levashov GV Morozov ES Severin VA Kabanov 1989 The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles: micelles as microcontainers for drug targeting FEBS Lett 258 343 345
29. A Lavasanifar J Samuel GS Kwon 2002 The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles composed of poly(ethylene oxide)-block-poly(N-hexyl stearate-l-aspartamide J Controlled Release 79 165 172
30. C Allen J Han Y Yu D Maysinger A Eisenberg 2000 Polycaprolactone-b- poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone J Controlled Release 51 275 286
31. A Rolland J O'Mullane P Goddard L Brookman K Petrak 1992 New macromolecular carriers for drugs. I. Preparation and characterization of poly(oxyethylene-b-isoprene-b-oxyethylene) block copolymer aggregates J Appl Polym Sci 44 1195 1203
32. NY Rapoport JN Herron WG Pitt L Pitina 1999 Micellar delivery of doxorubicin and its paramagnetic analog, ruboxyl, to HL-60 cells: effect of micelle structure and ultrasound on the intracellular drug uptake J Controlled Release 58 153 162
33. K Kataoka H Togawa A Harada K Yasugi T Matsumoto S Katayose 1996 Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonucleotide and cationic block copolymer in physiological saline Macromolecules 29 8556 8557
34. M Yokoyama S Inoue K Kataoka N Yui Y Sakurai 1989 Molecular design for missile drug: synthesis of adriamycin conjugated with IgG using poly(ethylene glycol)-poly(aspartic acid) block copolymer as intermediate carrier Makromol Chem 190 2041 2054
35. M Yokoyama M Miyauchi N Yamada T Okano Y Sakurai K Kataoka S Inoue 1990 Characterization and anti-cancer activity of micelle-forming polymeric anti-cancer drug, adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer Cancer Res 50 1693 1700
36. M Yokoyama N Yamada T Okano Y Sakurai K Kataoka S Inoue 1991 Toxicity and antitumor activity against solid tumors of micelle-forming polymeric drug and its extremely long circulation in blood Cancer Res 51 3229 3236
37. GS Kwon S Suwa M Yokoyama T Okano Y Sakurai K Kataoka 1994 Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates J Controlled Release 29 17 23
38. M Yokoyama T Okano Y Sakurai S Fukushima K Okamoto K Kataoka 1999 Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system J Drug Targeting 7 171 186
39. CJT Hoes W Potman WAR van Heeswijk J Mud BG de Grooth J Grave J Feijen 1985 Optimization of macromolecular prodrugs of the antitumor antibiotic adriamycin J Controlled Release 2 205 213
40. R Duncan P Kopeckova-Rejmanova J Strohalm I Hume HC Cable J Pohl JB Lloyd J Kopecek 1987 Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers I. Evaluation of daunomycin and puromycin conjugates in vitro Br J Cancer 55 165 174
41. N Endo N Umemoto Y Kato Y Takeda T Hara 1987 A novel covalent modification of antibodies at their amino groups with retention of antigen-binding activity J Immunol Methods 104 253 258
42. F Zunino G Pratesi A Micheloni 1989 Poly(carboxylic acid) polymers as carriers for anthracyclines J Controlled Release 10 65 73
43. Y Mizumura Y Matsumura M Yokoyama T Okano T Kawaguchi F Moriyasu T Kakizoe 2002 Incorporation of the anticancer agent KRN 5500 into polymeric micelles diminishes the pulmonary toxicity Jpn J Cancer Res 93 1237 1243
44. M Yokoyama P Opanasopit Y Maitani K Kawano T Okano 2004 Polymer design and incorporation method for polymeric micelle carrier system containing water-insoluble anti-cancer agent camptothecin J Drug Targeting 12 373 384
45. P Opanasopit M Yokoyama M Watanabe K Kawano Y Maitani T Okano 2004 Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting Pharm Res 21 2003 2010
46. M Yokoyama A Satoh Y Sakurai T Okano Y Matsumura T Kakizoe K Kataoka 1998 Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size J Controlled Release 55 219 229
47. T Hamaguchi Y Matsumura M Suzuki K Shimizu R Goda I Nakamura I Nakatomi M Yokoyama K Kataoka J Kakizoe 2005 NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend the therapeutic window of the drug British J Cancer 92 1240 1246